Dore-ME 75mg Tablet
By Dore-ME
Rx
10 Tablet in a Strip

Composition
Dosulepin(75mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
October, 2025

liver
There is limited information about using Dore-ME 75mg Tablet in patients with liver disease. It is recommended to consult with your doctor regarding its use in such cases.

kidney
Limited information is available on using Dore-ME 75mg Tablet in patients with kidney disease. Consult your doctor for guidance. Studies suggest being cautious when using this medicine with kidney disease.

alcohol
Dore-ME 75mg Tablet can lead to increased drowsiness when taken with alcohol. It is important to be cautious about combining the two.

driving
Caution is advised while driving with Dore-ME 75mg Tablet. If you notice any symptoms affecting your concentration or reaction time, refrain from driving.

pregnancy
Dore-ME 75mg Tablet is considered unsafe during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the risks versus benefits before recommending this medication. Consult your doctor for guidance.

breastfeeding
Dore-ME 75mg Tablet is likely unsafe while breastfeeding. Limited data indicates potential harm to the baby through breastmilk.
Habit Forming | No |
Chemical Class | Dibenzoxepin Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Tricyclic antidepressants |
₹104
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024